Korean scientist accused of faking journal article data is fired

Share this article:
Hwang Woo Suk, the Korean scientist who is alleged to have faked research on the cloning of human embryos in two papers published in the journal Science in 2004 and 2005, has been dismissed from his post at Seoul National University. Science has since retracted the articles. The school decided to fire Dr. Hwang following a disciplinary meeting, saying he and his co-workers caused the school to lose honor. Dr. Hwang has apologized in public for inflated data in the articles and has accused other researchers of deceiving him with falsified results.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...